Clinical and microbiologic characteristics of cefotaxime-non-susceptible Enterobacteriaceae bacteremia: a case control study

BACKGROUND: Cefotaxime plays an important role in the treatment of patients with bacteremia due to Enterobacteriaceae, although cefotaxime resistance is reported to be increasing in association with extended-spectrum β-lactamase (ESBL) and AmpC β-lactamase (AmpC). METHODS: We conducted a case-contro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Infect Dis
Autors principals: Noguchi, Taro, Matsumura, Yasufumi, Yamamoto, Masaki, Nagao, Miki, Takakura, Shunji, Ichiyama, Satoshi
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5219717/
https://ncbi.nlm.nih.gov/pubmed/28061869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-016-2150-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars